Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Ethinyl estradiol and norelgestromin is a combination of estrogen and progestin hormones delivered through a weekly skin patch to prevent pregnancy by stopping ovulation, thickening cervical mucus, and thinning the uterine lining. Some people are also prescribed it off-label to help regulate menstrual cycles, ease painful or heavy periods, and improve hormone-related acne, though effectiveness and risks vary by individual. Important details about who should avoid this patch, including smokers over 35 and those with a history of blood clots, migraines, or high blood pressure, are covered below along with common side effects and what to do about a detached patch. If you are noticing new symptoms such as breakthrough bleeding, headaches, leg pain, breast changes, or mood shifts, it helps to know whether they are expected adjustments or signals that need prompt attention. Take a free, instant, online symptom check to better understand what may be driving your symptoms and to get clear guidance on your next steps.
Last reviewed for medical accuracy: 09/24/2026
Ethinyl estradiol and norelgestromin are two synthetic hormones combined in a transdermal patch to prevent pregnancy and manage menstrual-related issues. This combination patch delivers a steady dose of estrogen (ethinyl estradiol) and progestin (norelgestromin) through the skin, reducing the risk of ovulation and creating an environment hostile to sperm.
Contraception
Menstrual Regulation
Acne Management (off-label)
Most side effects are mild and often improve after a few months. Common reactions include:
Always review the full prescribing information and discuss your personal risk factors with a healthcare professional.
Avoid the patch if you have:
Certain medications may reduce the patch’s effectiveness:
Always inform your doctor or pharmacist about all prescription meds, over-the-counter products, and supplements you use.
If you experience any of the following, remove the patch and speak to a doctor right away:
For less urgent concerns—new or worsening mood swings, persistent nausea, or irregular bleeding—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Ethinyl estradiol and norelgestromin provide a convenient, effective contraceptive option that also helps regulate menstrual cycles and may improve acne. Like all medications, they come with benefits and risks. Always review your personal health history and discuss any concerns with your healthcare provider. For anything life-threatening or serious, please speak to a doctor immediately.
(References)
* Creasy GW, Abrams LS, Fisher AC. Transdermal contraception. Semin Reprod Med. 2001 Dec;19(4):373-80. doi: 10.1055/s-2001-18645. PMID: 11727179.
* Creasy GW, Fisher AC, Hall N, Shangold GA. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile. J Reprod Med. 2003 Mar;48(3):179-86. PMID: 12698776.
* Goa KL, Warner GT, Easthope SE. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception. Treat Endocrinol. 2003;2(3):191-206. doi: 10.2165/00024677-200302030-00005. PMID: 15966567.
* Paris F, Rabeolina F, Balaguer P, Bacquet A, Sultan C. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line. Gynecol Endocrinol. 2007 Apr;23(4):193-7. doi: 10.1080/09513590701214414. PMID: 17505938.
* Taneepanichskul S. Norelgestromin/ethinyl estradiol transdermal system. J Med Assoc Thai. 2005 Oct;88 Suppl 2:S82-4. PMID: 17722322.
* Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007 Sep;29(7):467-509. PMID: 17982511.
* Crespi S, Kerrigan M, Sood V. Budget impact analysis of 8 hormonal contraceptive options. Am J Manag Care. 2013 Jul 1;19(7):e249-55. Epub 2013 Jul 1. PMID: 23919444.
* Sriprasert I, Stanczyk FZ, Archer DF. Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system. Expert Opin Pharmacother. 2015;16(12):1901-9. doi: 10.1517/14656566.2015.1056733. PMID: 26194214.
* Lavelanet AF, Rybin D, White KO. The pharmacokinetics of 12-week continuous contraceptive patch use. Contraception. 2017 Jun;95(6):578-585. doi: 10.1016/j.contraception.2017.03.002. Epub 2017 Mar 8. PMID: 28285154.
* Patel VP, Collins K, Heinemann K, Ngantung W, Saeedian M. A five-year cost-consequence analysis of extended-use etonogestrel implant versus other contraceptives. J Med Econ. 2026 Dec;29(1):66-76. doi: 10.1080/13696998.2025.2606600. Epub 2025 Dec 29. PMID: 41460288.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.